跳至主要内容
临床试验/NCT00313742
NCT00313742已完成4 期

An Assessment of the Impact of Performing Physical Exercise on the Maximum Plasma Glucose Decline in Subjects With Type 1 Diabetes Managed on a Basal Bolus Insulin Regimen: A Comparison of 3 Basal Insulin Treatments - Insulin Detemir, Insulin Glargine and NPH Insulin

Novo Nordisk A/S2 个研究点 分布在 2 个国家目标入组 51 人开始时间: 2006年4月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
51
试验地点
2
主要终点
The difference between plasma glucose concentrations immediately pre-exercise and the minimum plasma glucose concentrations (nadir) in the period 0-150 min following exercise

研究概览

简要总结

This trial is conducted in Europe. The aim of this research is to assess the impact of three basal (long-acting) insulin treatments on blood glucose levels in people with type 1 diabetes when performing physical exercise.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 1 Diabetes
  • Current basal-bolus insulin therapy
  • HbA1c < 10%
  • BMI < 32 kg/m2

排除标准

  • Proliferative Retinopathy / Maculopathy
  • Recurrent major hypoglycaemias
  • Impaired hepatic or renal function
  • Cardiac Problems
  • Uncontrolled hypertension

结局指标

主要结局

The difference between plasma glucose concentrations immediately pre-exercise and the minimum plasma glucose concentrations (nadir) in the period 0-150 min following exercise

时间窗: following 4 weeks of treatment

次要结局

  • Plasma glucose pre-exercise & post-exercise
  • Hypoglycaemia episodes (major and minor episodes) during exercise, afterwards & from end of study until 07:30 the following morning
  • Plasma glucose profile post-exercise
  • Incidence of adverse events during the trial

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验